Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma

NCT02399189 is registered in ClinicalTrials.gov with Jun Zhu as lead sponsor.

NCT NCT02399189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02399189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma
Lead sponsor
Jun Zhu
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2014
Completion date
April 30, 2019
Enrollment
39 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary central nervous system lymphoma